Cargando…
Linezolid resistance in patients with drug-resistant TB
Autores principales: | Vengurlekar, D., Walker, C., Mahajan, R., Dalal, A., Chavan, V., Galindo, M. A., Iyer, A., Mansoor, H., Silsarma, A., Isaakidis, P., Spencer, H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Union Against Tuberculosis and Lung Disease
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10321363/ https://www.ncbi.nlm.nih.gov/pubmed/37353865 http://dx.doi.org/10.5588/ijtld.22.0632 |
Ejemplares similares
-
Treatment outcomes of children and adolescents receiving drug-resistant TB treatment in a routine TB programme, Mumbai, India
por: Dhakulkar, Shubhangi, et al.
Publicado: (2021) -
Clinical utility of target-based next-generation sequencing for drug-resistant TB
por: Mansoor, H., et al.
Publicado: (2023) -
Pretomanid with bedaquiline and linezolid for drug-resistant TB: a comparison of prospective cohorts
por: Oelofse, S., et al.
Publicado: (2021) -
Linezolid resistance in patients with drug-resistant TB and treatment failure in South Africa
por: Wasserman, Sean, et al.
Publicado: (2019) -
Linezolid-Associated Optic Neuropathy in Drug-Resistant Tuberculosis Patients in Mumbai, India
por: Mehta, Salil, et al.
Publicado: (2016)